Eddit
Aus coViki
(Unterschied zwischen Versionen)
| (69 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
| + | |||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
| + | |||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
| − | + | *'''[[Clinical guidelines and advice]]''' | |
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
| − | |||
| − | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
| − | + | ||
| Zeile 40: | Zeile 27: | ||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
| − | |||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
| Zeile 48: | Zeile 34: | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
| − | |||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
| − | + | ||
| + | |||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | + | ||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
| + | |||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
| − | |||
| − | |||
| Zeile 68: | Zeile 53: | ||
*'''[[Systemic disease, any manifestations]]''' | *'''[[Systemic disease, any manifestations]]''' | ||
| + | |||
*'''[[Co-Infection]]''' | *'''[[Co-Infection]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
| + | |||
| + | |||
| + | |||
| + | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
| Zeile 81: | Zeile 68: | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
| + | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
| + | |||
| + | |||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
| + | |||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Kidney, urology]]''' | *'''[[Kidney, urology]]''' | ||
| − | |||
| − | |||
| − | |||
| + | *'''[[The morbid survivor]]''' | ||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| + | |||
| + | |||
| + | |||
| + | *'''[[Case series]]''' | ||
*'''[[Registries]]''' | *'''[[Registries]]''' | ||
| − | |||
| Zeile 125: | Zeile 106: | ||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Other routes of infection]]''' | *'''[[Other routes of infection]]''' | ||
| − | |||
| − | |||
| + | *'''[[Biophysics of aerosols]]''' | ||
| − | |||
*'''[[Passive protective equipment]]''' | *'''[[Passive protective equipment]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| + | *'''[[Running your hospital]]''' | ||
| + | *'''[[Mental aspects of health professionals]]''' | ||
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
| − | |||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
| + | |||
| Zeile 164: | Zeile 138: | ||
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
| − | |||
| Zeile 174: | Zeile 147: | ||
*'''[[Origin of Covid19]]''' | *'''[[Origin of Covid19]]''' | ||
| − | |||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| + | *'''[[Remission, recurrence and persistence]]''' | ||
| + | |||
| + | |||
| + | *'''[[Failure of executive measures]]''' | ||
---- | ---- | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
| − | |||
| − | |||
*'''[[Political abuse of Covid19]]''' | *'''[[Political abuse of Covid19]]''' | ||
| − | + | ||
| + | |||
*'''[[Lost people]]''' | *'''[[Lost people]]''' | ||
*'''[[Lost civilization]]''' | *'''[[Lost civilization]]''' | ||
| + | |||
---- | ---- | ||
*'''[[History of covid19 exploration]]''' | *'''[[History of covid19 exploration]]''' | ||
| − | |||
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
| + | |||
| + | |||
*'''[[Research tools]]''' | *'''[[Research tools]]''' | ||
| + | |||
| + | |||
| + | |||
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | ||
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} | ||
*'''[[PrePrint scene]]''' | *'''[[PrePrint scene]]''' | ||
| + | |||
| + | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
| + | |||
*'''[[Current state of coviki.org]]''' | *'''[[Current state of coviki.org]]''' | ||
| + | *'''[[on-topic personal thoughts]]''' | ||
Aktuelle Version vom 7. Juni 2020, 22:19 Uhr
27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system
